NCT04086264 IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04084145 National Unified Renal Translation Research Enterprise - Chronic Kidney Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04080856 Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada Status COMPLETED Phase N/A
NCT04073303 BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence Status COMPLETED Phase PHASE3
NCT04070768 Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 Status COMPLETED Phase PHASE1
NCT04064827 A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) Status TERMINATED Phase PHASE3
NCT04042740 Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection Status COMPLETED Phase PHASE2
NCT04041050 A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04040621 Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia Status TERMINATED Phase PHASE1
NCT04030962 A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease Status COMPLETED Phase PHASE1/PHASE2
NCT04026113 Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) Status COMPLETED Phase PHASE3
NCT04010968 Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT03999801 Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Status ENROLLING_BY_INVITATION Phase PHASE2
NCT03987958 A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03982394 Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase N/A
NCT03978520 A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT03969888 A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 Status COMPLETED Phase PHASE2
NCT03955783 Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT03951077 Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome Status COMPLETED Phase PHASE2